Skip to content

ImagenSPECT 3.0

by Cardiovascular Imaging Technologies L.L.C.

ImagenSPECT 3.0 is a SPECT system application software (FDA Class II) made by Cardiovascular Imaging Technologies L.L.C., cleared under FDA 510(k) K201933 on 11 Aug 2020 (1 earlier submission) and listed in FDA GUDID since 2 Nov 2020 (UDI-DI 00862611000349), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00862611000349 UDI-DI Date2 Nov 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Special NumberK201933 Date11 Aug 2020DecidedStatusActive

Official records

From the FDA record

Device description
ImagenSPECT™ 3.0 is a Windows application which allows physicians and healthcare professionals to inspect, reconstruct and reorient myocardial perfusion SPECT images. The system processes gated and ungated SPECT cardiac images to create 3D tomographic data. The user can correct for patient motion, change filter settings, change reconstruction settings, range of reconstruction, and reorientation angles. The application also models the influence of distance dependent blur. The use of this system is limited to qualified, licensed healthcare providers (radiologists, nuclear cardiologists or nuclear medicine physicians) trained in the use of nuclear medicine imaging devices. This software also processes, display and performs quantitative calculations of LVEF on multigated acquisition blood pool scans (MUGA). ImagenSPECT™ 3.0 is used to quantitate the uptake of 99mTc pyrophosphate in early and late planar and SPECT studies. The ImagenSPECT™ 3.0 system is designed to take nuclear medicine data from commercially available SPECT systems and process the data into a format that can be visualized by a separate computer program or workstation. In addition, quarter-counts, half dose and/or half-time scans can be reconstructed with ImagenSPECT™ 3.0 using resolution recovery, iterative reconstruction and is equivalent to the predicate ImagenSPECT™ (k152503) using half-counts and full counts (full-time scan, half dose/ half-time, full dose).
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K201933 decided 11 Aug 2020 Active· +1 more in the status table
  • FDA GUDID UDI-DI 00862611000349 listed 2 Nov 2020 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K152503
  2. Cleared FDA 510(k) K201933
  3. Listed FDA GUDID 00862611000349

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
ImagenSPECT
Generic name
SPECT system application software
Model / reference
3.0
Primary DI / UDI-DI
00862611000349
510(k) Number
FDA product code
KPS, LLZ
GMDN term
SPECT system application software
Device class
Class II
Regulation number
892.1200, 892.2050
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code KPS (System, Tomography, Computed, Emission).

Other devices from Cardiovascular Imaging Technologies

  • ImagenQ 3.0

    Class II
  • ImagenQ 2.1

    Class II
  • ImagenQ V2.0

    Class II
  • ImagenUniversal 2.0

    Class II

See all devices from Cardiovascular Imaging Technologies →

Properties

Other properties (15, all answered No)